Granules Pharma completes USFDA PADE Inspection with zero observations
The inspection was conducted at Granules Pharmaceuticals from July 31, 2023 to August 03, 2023
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Granules Pharmaceuticals
Granules Pharmaceuticals receives ANDA approval for Amphetamine mixed salts from US FDA
The product is bioequivalent to the Reference Listed Drug (RLD) product Adderall of Teva Women’s Health Inc, and would be…
Granules India gets Health Canada nod to market arthritis tablets
The drug will be manufactured at the company's manufacturing facility located in Gagillapur, Hyderabad